Related references
Note: Only part of the references are listed.Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease
Alberto Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2023)
Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
Milton Packer
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Role of Klotho in the Development of Essential Hypertension
Mehmet Kanbay et al.
HYPERTENSION (2021)
Pirfenidone is a renal protective drug: Mechanisms, signalling pathways, and preclinical evidence
Xue Bai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Kidney disease genetic risk variants alter lysosomal beta-mannosidase (MANBA) expression and disease severity
Xiangchen Gu et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Renal tubule Cpt1a overexpression protects from kidney fibrosis by restoring mitochondrial homeostasis
Veronica Miguel et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
Abeda Jamadar et al.
CELL DEATH & DISEASE (2021)
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
Giovanna Castoldi et al.
ACTA DIABETOLOGICA (2021)
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD
Glenn M. Chertow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The program of renal fibrogenesis is controlled by microRNAs regulating oxidative metabolism
Veronica Miguel et al.
REDOX BIOLOGY (2021)
Kidney pericyte hypoxia-inducible factor regulates erythropoiesis but not kidney fibrosis
Szu-Yu Pan et al.
KIDNEY INTERNATIONAL (2021)
Gain of 'FAOnction', Loss of Fibrosis
Rebekah J. Nicholson et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Nicotinamide and acute kidney injury
Miguel Fontecha-Barriuso et al.
CLINICAL KIDNEY JOURNAL (2021)
Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion
Hui Geng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2021)
Decoding myofibroblast origins in human kidney fibrosis
Christoph Kuppe et al.
NATURE (2021)
A collagen-binding protein enables molecular imaging of kidney fibrosis in vivo
Maike Baues et al.
KIDNEY INTERNATIONAL (2020)
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
Luca Richeldi et al.
LANCET RESPIRATORY MEDICINE (2020)
MiR-9-5p protects from kidney fibrosis by metabolic reprogramming
Marta Fierro-Fernandez et al.
FASEB JOURNAL (2020)
Multiparametric magnetic resonance imaging shows promising results to assess renal transplant dysfunction with fibrosis
Octavia Bane et al.
KIDNEY INTERNATIONAL (2020)
NAD+ homeostasis in renal health and disease
Kenneth M. Ralto et al.
NATURE REVIEWS NEPHROLOGY (2020)
IL-11 in cardiac and renal fibrosis: Late to the party but a central player
Benjamin Corden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
Daisuke Inoue et al.
CLINICAL NEPHROLOGY (2020)
PDGFR-β and kidney fibrosis
Alberto Ortiz
EMBO MOLECULAR MEDICINE (2020)
Dysregulated mesenchymal PDGFR-β drives kidney fibrosis
Eva M. Buhl et al.
EMBO MOLECULAR MEDICINE (2020)
Kidney Structural Features from Living Donors Predict Graft Failure in the Recipient
Naim Issa et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Kidney Histopathology and Prediction of Kidney Failure: A Retrospective Cohort Study
Michael T. Eadon et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Exome Sequencing and Identification of Phenocopies in Patients With Clinically Presumed Hereditary Nephropathies
Korbinian M. Riedhammer et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2020)
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial
Athol U Wells et al.
Lancet Respiratory Medicine (2020)
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George et al.
LANCET RESPIRATORY MEDICINE (2020)
Targeting the progression of chronic kidney disease
Marta Ruiz-Ortega et al.
NATURE REVIEWS NEPHROLOGY (2020)
Reversal of TGF beta 1-Driven Profibrotic State in Patients with Pulmonary Fibrosis
Harold A. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Larger Nephron Size and Nephrosclerosis Predict Progressive CKD and Mortality after Radical Nephrectomy for Tumor and Independent of Kidney Function
Aleksandar Denic et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Spatiotemporal ATP Dynamics during AKI Predict Renal Prognosis
Shinya Yamamoto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis
Ji Zhang et al.
CELL REPORTS MEDICINE (2020)
Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis
Emilia Bigaeva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Autotaxin Inhibitor Protects from Chronic Allograft Injury in Rat Kidney Allotransplantation
Monica Cortinovis et al.
NEPHRON (2020)
Nintedanib-induced glomerular microangiopathy: a case report
Masataka Hasegawa et al.
CEN CASE REPORTS (2020)
Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules
Jinpeng Li et al.
JCI INSIGHT (2020)
Pentraxin-2 is Associated with Renal Fibrosis in Patients Undergoing Renal Biopsy
Taner Basturk et al.
CLINICS (2020)
Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis
Jonatan Barrera-Chimal et al.
KIDNEY INTERNATIONAL (2019)
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
Pantelis Sarafidis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
PGC-1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI
Miguel Fontecha-Barriuso et al.
JOURNAL OF PATHOLOGY (2019)
Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
Joachim H. Ix et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Elastin imaging enables noninvasive staging and treatment monitoring of kidney fibrosis
Qinxue Sun et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
Ganesh Raghu et al.
LANCET RESPIRATORY MEDICINE (2019)
The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage
Norihiko Sakai et al.
SCIENTIFIC REPORTS (2019)
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
K. R. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling
Petros Andrikopoulos et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem
Alberto Ortiz et al.
NEFROLOGIA (2019)
Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis
Nathan L. Price et al.
JCI INSIGHT (2019)
Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
Juan F. Navarro-Gonzalez et al.
DIABETES CARE (2018)
Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity
Jana Grune et al.
HYPERTENSION (2018)
Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA
Nicholas M. Selby et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
A sodium-glucose cotransporter 2 inhibitor attenuates renal capillary injury and fibrosis by a vascular endothelial growth factor-dependent pathway after renal injury in mice
Yifan Zhang et al.
KIDNEY INTERNATIONAL (2018)
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
Kyle J. Foreman et al.
LANCET (2018)
Lysophosphatidic Acid Protects Against Endotoxin-Induced Acute Kidney Injury
Koryun Mirzoyan et al.
INFLAMMATION (2017)
Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice
Hui Ying Li et al.
KIDNEY INTERNATIONAL (2017)
IL-11 is a crucial determinant of cardiovascular fibrosis
Sebastian Schafer et al.
NATURE (2017)
Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
Pedro Magalhaes et al.
SCIENTIFIC REPORTS (2017)
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
Flavio Vincenti et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Nintedanib, a triple tyrosine kinase inhibitor, attenuates renal fibrosis in chronic kidney disease
Feng Liu et al.
CLINICAL SCIENCE (2017)
Treatment of Renal Fibrosis-Turning Challenges into Opportunities
Barbara M. Klinkhammer et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2017)
Pharmacokinetic and pharmacometabolomic study of pirfenidone in normal mouse tissues using high mass resolution MALDI-FTICR-mass spectrometry imaging
Na Sun et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2016)
Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease
Naoki Nakagawa et al.
JCI INSIGHT (2016)
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways
Ivan G. Gomez et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
MicroRNA-21 in Glomerular Injury
Jennifer Y. Lai et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development
Hyun Mi Kang et al.
NATURE MEDICINE (2015)
TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast
Alvaro C. Ucero et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Pirfenidone for Diabetic Nephropathy
Kumar Sharma et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
Howard Trachtman et al.
KIDNEY INTERNATIONAL (2011)
Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration
Yoichi Kakuta et al.
TRANSPLANT INTERNATIONAL (2011)
Pirfenidone Is Renoprotective in Diabetic Kidney Disease
Satish P. RamachandraRao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis
Monique E. Cho et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats
Noriko Yamabe et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Share Paper
